ONO PHARMACEUT.ONO PHARMACEUT.ONO PHARMACEUT.

ONO PHARMACEUT.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.37 B‬EUR
‪783.64 M‬EUR
‪3.08 B‬EUR
‪316.34 M‬
Beta (1Y)
0.59

About ONO PHARMACEUTICAL CO

CEO
Gyo Sagara
Headquarters
Osaka
Website
Founded
1947
ISIN
JP3197600004
FIGI
BBG000C4Q8N6
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ONO PHARMACEUT. stocks are traded under the ticker ON4.
ONO PHARMACEUT. is going to release the next earnings report on Jul 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.27 EUR per share, whereas the estimation was 0.31 EUR resulting in a −14.65% surprise. The estimated earnings for the next quarter are 0.38 EUR per share. See more details about ONO PHARMACEUT. earnings.
ONO PHARMACEUT. revenue for the last quarter amounts to ‪690.70 M‬ EUR despite the estimated figure of ‪754.47 M‬ EUR. In the next quarter revenue is expected to reach ‪670.33 M‬ EUR.
Yes, you can track ONO PHARMACEUT. financials in yearly and quarterly reports right on TradingView.
ON4 net income for the last quarter is ‪106.75 M‬ EUR, while the quarter before that showed ‪231.49 M‬ EUR of net income which accounts for −53.88% change. Track more ONO PHARMACEUT. financial stats to get the full picture.
ONO PHARMACEUT. dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO PHARMACEUT. stock right from TradingView charts — choose your broker and connect to your account.
ON4 reached its all-time high on Jul 15, 2022 with the price of 27.6 EUR, and its all-time low was 13.2 EUR and was reached on Apr 30, 2024. View more price dynamics on ON4 chart.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on ONO PHARMACEUT. future price: according to them, ON4 price has a max estimate of 18.19 EUR and a min estimate of 11.93 EUR. Watch ON4 chart and read a more detailed ONO PHARMACEUT. stock forecast: see what analysts think of ONO PHARMACEUT. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO PHARMACEUT. EBITDA is ‪1.14 B‬ EUR, and current EBITDA margin is 36.06%. See more stats in ONO PHARMACEUT. financial statements.